Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Core EBITDA Growth

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.6932.55-13.1679.8240.81

What is the latest Core EBITDA Growth ratio of MARKSANS PHARMA ?

The latest Core EBITDA Growth ratio of MARKSANS PHARMA is 27.69 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.69
Mar202332.55
Mar2022-13.16
Mar202179.82
Mar202040.81

How is Core EBITDA Growth of MARKSANS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 27.69
-14.93
Mar2023 32.55
Positive
Mar2022 -13.16
Negative
Mar2021 79.82
95.59
Mar2020 40.81 -

Other Financial Ratios of MARKSANS PHARMA


Compare Core EBITDA Growth ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹12,932.1 Cr -3.8% -18% 80% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,145.0 Cr -2% 2.1% 42.6% Stock Analytics
DIVIS LABORATORIES ₹156,280.0 Cr -3.5% -3.4% 49.9% Stock Analytics
CIPLA ₹120,379.0 Cr -2.6% -0.6% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr -2.7% 8.9% 14.2% Stock Analytics
ZYDUS LIFESCIENCES ₹96,774.5 Cr -1% -1.7% 36.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-3.8%

-18%

80%

SENSEX

-0.4%

-3.7%

7.9%


You may also like the below Video Courses